- Home
- Partners
- NIH/National Institute of Allergy and Infectious Diseases
NIH/National Institute of Allergy and Infectious Diseases
NIH/National Institute of Allergies and Infectious Disease (NIAID) is part of the National Institute of Health, funded through theUSA Department of Health and Human Services, a cabinet level agency. NIAID has been in existence for over 50 years and its primary role is to conduct, support and find effective treatments for infectioius, immunological and allergic diseases. Some of its efforts are conducted in-house, but a significant amount of research funds are awarded to scientists, labs and universities to accomplish NIAID goals. NIAID credits itself with developing new vaccines, new therapies and new diagnostic tests which have aided millions of people.
AddressNIAID Office of Communications and Government Relations 6610 Rockledge Drive, MSC 6612 Bethesda, MD 20892-6612 United States of AmericaWebsite//www3.niaid.nih.gov/Wikipedia//en.wikipedia.org/wiki/National_Institute_of_Allergy_and_Infectious_DiseasesSome content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
- Date
- Rank
- LiveRank
- Popular
Diseases, Conditions, Syndromes The amount of SARS-CoV-2 antigen measured in the blood of patients hospitalized with COVID-19 is associated with illness severity and other clinical outcomes, according to a new study published in the Annals of Internal Medicine. ... Aug 29, 2022 0 54 Diseases, Conditions, Syndromes Lessons learned from
the public health responses to the HIV and COVID-19 pandemics should help guide the response to the current outbreak of monkeypox, National Institutes of Health experts write in an editorial published ... Aug 24, 2022 0 7 ImmunologySARS-CoV-2 antigen levels linked to patient outcomes
NIH experts review monkeypox challenges
Monoclonal antibody reduces asthma attacks in urban youth
A National Institutes of Health clinical trial has found that a monoclonal antibody, mepolizumab, decreased asthma attacks by 27% in Black and Hispanic children and adolescents who have a form of severe asthma, are prone ...
Aug 10, 2022
0
37
Diseases, Conditions, Syndromes
NIH updates Hepatitis B Strategic Research Plan
The National Institutes of Health has updated its Strategic Plan for NIH Research to Cure Hepatitis B, a roadmap for ending the hepatitis B epidemic, focused on developing a cure as well as improved strategies for vaccination, ...
Aug 01, 2022
0
3
HIV & AIDS
New insights into HIV latent cells yield potential cure targets
In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC) and their collaborators ...
Jul 27, 2022
0
7
Immunology
Vaccine-induced immune response to omicron wanes substantially over time
Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial ...
Jul 19, 2022
0
102
Medications
Combination anti-HIV antibody infusions suppress virus for prolonged period
Individuals with HIV who began taking antiretroviral therapy (ART) in the early stages of infection achieved a lengthy period of HIV suppression without ART after receiving two broadly neutralizing anti-HIV antibodies (bNAbs), ...
Jun 01, 2022
0
64
Medical research
Food allergy is associated with lower risk of SARS-CoV-2 infection
A National Institutes of Health-funded study has found that people with food allergies are less likely to become infected with SARS-CoV-2, the virus that causes COVID-19, than people without them. In addition, while previous ...
Jun 01, 2022
0
42
Diseases, Conditions, Syndromes
Vaccine for rare but deadly mosquito-borne viruses shows promise in clinical trial
A vaccine for eastern equine encephalitis virus (EEEV), western equine encephalitis virus (WEEV), and Venezuelan equine encephalitis virus (VEEV) was found to be safe, well-tolerated and induced a neutralizing antibody response ...
May 12, 2022
0
7
Diseases, Conditions, Syndromes
NIH experts discuss controlling COVID-19 in commentary on herd immunity
Achieving classical herd immunity against SARS-CoV-2, the virus that causes COVID-19, may not be attainable, according to a new perspective published in The Journal of Infectious Diseases. However, widespread use of currently ...
Mar 31, 2022
0
73